---
title: "GenSight Biologics cash position falls to EUR 1.7 million as of June 30, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292097990.md"
description: "GenSight Biologics reported a cash position of EUR 1.7 million as of June 30, 2026, down from EUR 3.2 million in March. The company collected EUR 6.8 million from early access programs in H1. Heights Capital requested deferring convertible bond amortization to December 2027. Inventory exceeds 60 vials, supporting patients through mid-2027, with Phase III RECOVER supply manufacturing planned post-transfer confirmation."
datetime: "2026-07-08T17:03:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292097990.md)
  - [en](https://longbridge.com/en/news/292097990.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292097990.md)
---

# GenSight Biologics cash position falls to EUR 1.7 million as of June 30, 2026

-   Gensight Biologics reported cash and cash equivalents of EUR 1.7 million as of June 30, down from EUR 3.2 million at March 31. \* Heights Capital requested deferral of the June convertible bond amortization to end-December 2027. \* Collected EUR 6.8 million from paid early access programs in H1, including EUR 4.3 million in Q2. \* Inventory exceeds 60 vials, expected to support patients through end-H1 2027; Phase III RECOVER supply manufacturing planned post-summer transfer confirmation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gensight Biologics SA published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

## Related News & Research

- [EnBW International Finance, EnBW subsidiary, posts EUR 4.15 million H1 net profit](https://longbridge.com/en/news/294210805.md)
- [Lagardère announces availability of 2026 half-year financial report](https://longbridge.com/en/news/294090180.md)
- [JSL updates financial events calendar for 2026](https://longbridge.com/en/news/294067473.md)
- [Azaria Rental SOCIMI announces EUR 7.6 million dividend distribution](https://longbridge.com/en/news/294226471.md)
- [Embention publishes shareholder meeting minutes for June 30, 2026 meeting](https://longbridge.com/en/news/294186429.md)